R Squared Ltd Invests $30,000 in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

R Squared Ltd purchased a new position in Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 1,470 shares of the company’s stock, valued at approximately $30,000.

A number of other large investors also recently modified their holdings of the business. Investment Research & Advisory Group Inc. acquired a new stake in shares of Guardian Pharmacy Services in the 4th quarter worth about $34,000. Stephens Inc. AR acquired a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth about $189,000. Virtu Financial LLC acquired a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth about $279,000. Barclays PLC acquired a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $311,000. Finally, Point72 DIFC Ltd acquired a new position in Guardian Pharmacy Services during the 3rd quarter valued at about $573,000.

Analysts Set New Price Targets

Several research firms have commented on GRDN. Truist Financial raised their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th. Raymond James began coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They set an “outperform” rating and a $21.00 target price on the stock. Finally, Stephens began coverage on shares of Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They set an “overweight” rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Price Performance

NYSE:GRDN opened at $22.07 on Tuesday. Guardian Pharmacy Services, Inc. has a twelve month low of $14.16 and a twelve month high of $25.74. The firm’s 50-day simple moving average is $22.16.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of $0.19 by ($2.19). The firm had revenue of $314.39 million for the quarter, compared to the consensus estimate of $303.21 million. Equities research analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Activity

In other Guardian Pharmacy Services news, Director Steven D. Cosler bought 7,000 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were bought at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the acquisition, the director now directly owns 17,713 shares of the company’s stock, valued at approximately $375,869.86. This trade represents a 65.34 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.